Kazumasa Ikeda

1000 citations

26 papers · 849 indexed · h-index 14

Pharmacology top 2%
Oncology top 10%
- Colorectal Cancer Treatments and Studies 7
- Drug Transport and Resistance Mechanisms 3
- Cancer Treatment and Pharmacology 3
- Pancreatic and Hepatic Oncology Research 3
Gastroenterology top 10%
Pulmonary and Respiratory Medicine top 10%
- Gastric Cancer Management and Outcomes 4
Hepatology
Molecular Biology
- Biochemical and Molecular Research 3
Genetics
- Chronic Lymphocytic Leukemia Research 2
Pathology and Forensic Medicine
- Vitamin D Research Studies 2

Co-authors: Sekio Nagayama Yasuro KAWAGUCHI Eiji Matsushima Kunihiro Yoshisue James C. Yao Jaffer A. Ajani Josephine Faust Charles A. Tyson
Cited by: Pharmacology Oncology Gastroenterology
Journals: Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)The Journal of Immunology (1 paper)
Partner nations: Japan United States South Korea

In The Last Decade

Kazumasa Ikeda

26 papers receiving 830 citations

Peers

Countries citing papers authored by Kazumasa Ikeda

Since Specialization

Citations

This map shows the geographic impact of Kazumasa Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazumasa Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazumasa Ikeda more than expected).

Fields of papers citing papers by Kazumasa Ikeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazumasa Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazumasa Ikeda. The network helps show where Kazumasa Ikeda may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kazumasa Ikeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kazumasa Ikeda Line = papers co-authored together Kazumasa Ikeda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Utilizing environmental DNA and imaging to study the deep-sea fish community of Takuyo-Daigo Seamount SHILAP Revista de lepidopterología ·Akira Iguchi,Miyuki Nishijima,Eri Ikeuchi,Hiroyuki Yokooka,Hideki Sugishima,Kazumasa Ikeda,Ryuichi Miwa,Yoshiro Sekido,Nozomu Iwasaki,Masahiro Suzumura,Ayumi Tsukasaki,Yuichiro Tanaka,Shogo Kato,Jumpei Minatoya,Nobuyuki Okamoto,Taiga Kunishima,Yuji Ise,Atsushi Suzuki	2024	4
2	Molecular Cytogenetic Analysis of the Critically Endangered <i>Trigonotis radicans</i> var. <i>radicans</i> and var. <i>sericea</i> and Allied Species in Japan CYTOLOGIA ·Kazumasa Ikeda,Syunichi Sato,Hideyuki Matoba,Katsuya Nagano,Hiroshi Uchiyama	2013	7
3	Vitamin D Receptor Activation Enhances Benzo[a]pyrene Metabolism via CYP1A1 Expression in Macrophages Drug Metabolism and Disposition ·Manabu Matsunawa,Daisuke Akagi,Shigeyuki Uno,Kaori Endo‐Umeda,Sachiko Yamada,Kazumasa Ikeda,Makoto Makishima	2012	31
4	Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia Journal of Lipid Research ·Michiyasu Ishizawa,Manabu Matsunawa,Ryutaro Adachi,Shigeyuki Uno,Kazumasa Ikeda,Hiroyuki Masuno,Masato Shimizu,Ken‐ichi Iwasaki,Sachiko Yamada,Makoto Makishima	2008	89
5	Relationship between p53 status and 5-fluorouracil sensitivity in 3 cell lines Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Hiroaki Oka,Kazumasa Ikeda,Hiromi Yoshimura,Akinobu Ohuchida,Masamitsu Honma	2006	14
6	The heat shock protein inhibitor KNK437 induces neurite outgrowth in PC12 cells Neuroscience Letters ·Tomoko Koike,Shigeyuki Uno,Michiyasu Ishizawa,Hideo Takahashi,Kazumasa Ikeda,Shin‐ichi Yokota,Makoto Makishima	2006	14
7	Phase I Pharmacokinetic Study of S-1 Plus Cisplatin in Patients With Advanced Gastric Carcinoma Journal of Clinical Oncology ·Jaffer A. Ajani,Josephine Faust,Kazumasa Ikeda,James C. Yao,Hiroshi Anbe,K. Carr,Michele Houghton,P. D. Urrea	2005	158
8	Incorporation of anthraquinonyl group into λ‐Cro repressor protein for strand‐ and position‐specific photocleavage of double‐stranded DNA Biopolymers ·Hiroshi Sasaki,Kazumasa Ikeda,Maya Suzuki,Keiko Ninomiya,Masahiko Sisido	2004	1
9	Comparison of the Pharmacokinetics of S-1, an Oral Anticancer Agent, in Western and Japanese Patients Journal of Pharmacokinetics and Pharmacodynamics ·Emmanuelle Comets,Kazumasa Ikeda,Paulo M. Hoff,P. Fumoleau,J. Wanders,Yusuke Tanigawara	2003	27
10	Population study of expression of thymidylate synthase and dihydropyrimidine dehydrogenase in patients with solid tumors International Journal of Molecular Medicine ·Masakazu Fukushima,Masao Morita,Kazumasa Ikeda,Sekio Nagayama	2003	40
11	A novel mutant allele of the CYP2A6 gene (CYP2A611) found in a cancer patient who showed poor metabolic phenotype towards tegafur Pharmacogenetics* ·Satoshi Daigo,Yoshiki Takahashi,Masaki Fujieda,Noritaka Ariyoshi,Hiroshi Yamazaki,Wasaburo Koizumi,Satoshi Tanabe,Katsunori Saigenji,Sekio Nagayama,Kazumasa Ikeda,Yasuhiko Nishioka,Tetsuya Kamataki	2002	102
12	Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum Molecular and Cellular Biochemistry ·Kazumasa Ikeda,Kyoko Miura,Seiichiro Himeno,Nobumasa Imura,Akira Naganuma	2001	19
13	Tissue Distribution and Biotransformation of Potassium Oxonate after Oral Administration of a Novel Antitumor Agent (Drug Combination of Tegafur, 5-Chloro-2,4-dihydroxypyridine, and Potassium Oxonate) to Rats Drug Metabolism and Disposition ·Kunihiro Yoshisue,Hirotoshi MASUDA,Eiji Matsushima,Kazumasa Ikeda,Sekio Nagayama,Yasuro KAWAGUCHI	2000	33
14	Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro. PubMed ·Kazumasa Ikeda,Kunihiro Yoshisue,Eiji Matsushima,Sekio Nagayama,Kaoru Kobayashi,Charles A. Tyson,Kan Chiba,Yasuro KAWAGUCHI	2000	146
15	T Cell Recognition of Hypervariable Region-1 from Hepatitis C Virus Envelope Protein with Multiple Class II MHC Molecules in Mice and Humans: Preferential Help for Induction of Antibodies to the Hypervariable Region The Journal of Immunology ·Mutsunori Shirai,Tatsumi Arichi,Ming Chen,Mikio Nishioka,Kazumasa Ikeda,Hidemi Takahashi,Nobuyuki Enomoto,Takafumi Saito,Marian Major,Teruko Nakazawa,Toshitaka Akatsuka,Stephen M. Feinstone,Jay A. Berzofsky	1999	41
16	Disposition of Components of New Anti-cancer Drug S-1(1): Absorption and Excretion of Components of S-1 after Single Administration to Rats. Drug Metabolism and Pharmacokinetics ·Hirotoshi MASUDA,Kazumasa Ikeda,Kisako TOKO,Sekio Nagayama,Yasuro KAWAGUCHI,Katsuyuki HORI,Toshiyuki MASHIKO,Yoshio ESUMI	1997	2
17	Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs. PubMed ·Haruhiro Okuda,Takahito Nishiyama,Kenichiro Ogura,Sekio Nagayama,Kazumasa Ikeda,Shuji Yamaguchi,Yoshimasa Nakamura,Yasuro KAWAGUCHI,Tadashi Watabe	1997	81
18	Purification and characterization of canine manganese superoxide dismutase and its immunohistochemical localization in canine heart compared with that of copper-zinc superoxide dismutase The International Journal of Biochemistry & Cell Biology ·Kazumasa Ikeda,Shigeru Matsumi,T Magara,Shigeki Nakagawa	1995	2
19	Establishment and Characterization of Methylmercury-Resistant PC12 Cell Line Environmental Health Perspectives ·Kyoko Miura,Thomas W. Clarkson,Kazumasa Ikeda,Akira Naganuma,Nobumasa Imura	1994	2
20	Human brain hypoxanthine guanine phosphoribosyltransferase: Structural and functional comparison with erythrocyte hypoxanthine guanine phosphoribosyltransferase International Journal of Biochemistry ·Kazumasa Ikeda,Harudo Suzuki,Shigeki Nakagawa	1986	7

About Kazumasa Ikeda

Kazumasa Ikeda is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics, having authored 26 papers that have together received 849 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (7 papers), Gastric Cancer Management and Outcomes (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Biochemical and Molecular Research (3 papers), Cancer Treatment and Pharmacology (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Vitamin D Research Studies (2 papers). The work is most often cited by research in Pharmacology (180 citations), Oncology (429 citations) and Gastroenterology (54 citations). Kazumasa Ikeda has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Sekio Nagayama, Yasuro KAWAGUCHI, Eiji Matsushima, Kunihiro Yoshisue, James C. Yao, Jaffer A. Ajani, Josephine Faust, Charles A. Tyson, Kan Chiba and Kaoru Kobayashi. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact